Evidence map›Paper›PMID 37077817›Full record

SynthesisFrontiers in pharmacology2023

Okra ameliorates hyperglycaemia in pre-diabetic and type 2 diabetic patients: A systematic review and meta-analysis of the clinical evidence.

Kabelo Mokgalaboni, Sogolo Lucky Lebelo, Perpetua Modjadji, Saba Ghaffary

Open access · goldAbstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 12 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 12 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Comparative effectiveness of semaglutideFrontiers in pharmacology · 2025
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Effect ofInternational journal of molecular sciences · 2024
    Pooled it
  11. Pooled it
  12. Effect of boswellia (Frontiers in clinical diabetes and healthcare · 2024
    Pooled it
  13. Article
  14. Review
  15. Investigating the Impact ofPlants (Basel, Switzerland) · 2026
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Kabelo MokgalaboniDepartment of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, Florida Campus, University of South Africa, Roodepoort, South Africa.
Sogolo Lucky LebeloDepartment of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, Florida Campus, University of South Africa, Roodepoort, South Africa.
Perpetua ModjadjiNon-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
Saba GhaffaryHematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
University of South Africa · ZASouth African Medical Research Council · ZATabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antioxidanthyperglycaemiainflammationokrapre-diabetestype 2 diabetes

Identifiers

PMID37077817
PMCPMC10107009
OpenAlexW4362581092

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.